| References |
|
|
Abzug MA
(2004)
Presentation, diagnosis, and management of enterovirus infections in neonates.
Pediatric Drugs
6:
1–10.
|
|
|
Barnard DL
(2006)
Current status of anti‐picornavirus therapies.
Current Pharmaceutical Design
12:
1379–1390.
|
|
|
Begier EM,
Oberste MS,
Landry ML et al.
(2008)
An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico.
Clinical Infectious Diseases
47:
616–623.
|
|
|
Caggana M,
Chan P and
Ramsingh A
(1993)
Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.
Journal of Virology
67:
4797–4803.
|
|
|
Chu PY,
Ke GM,
Chen YS et al.
(2010)
Molecular epidemiology of Coxsackievirus B3.
Infection, Genetics and Evolution
10:
777–784.
|
|
|
Committee on the ECHO viruses – National Foundation for Infantile Paralysis
(1955)
Enteric Cytopathic Human Orphan (ECHO) viruses.
Science
122:
1187–1188.
|
|
|
Dalldorf G and
Sickles GM
(1948)
An unidentified, filterable, agent isolated from the feces of children with paralysis.
Science
108:
61–62.
|
|
|
Desmond RA,
Accortt NA,
Talley L et al.
(2006)
Enterovirus meningitis: natural history and outcome of pleconaril therapy.
Antimicrobial Agents Chemotherapy
50:
2409–2417.
|
|
|
Dunn JJ,
Bradrick SS,
Chapman NM et al.
(2003)
The stem loop II within the 5′ nontranslated region of clinical Coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Journal of Infectious Diseases
187:
1552–1561.
|
|
|
Fowles AL,
Honarmand S,
Glaser C et al.
(2008)
Enterovirus‐associated encephalitis in the California encephalitis project, 1998–2005.
Journal of Infectious Diseases
198:
1685–1691.
|
|
|
Grist NR,
Bell EJ and
Assaas F
(1978)
Enteroviruses in human disease.
Progress in Medical Virology
24:
114–157.
|
|
|
Hauri AM,
Schimmelpfennig M,
Walter‐Domes M et al.
(2005)
An outbreak of viral meningitis associated with a public swimming pond.
Epidemiology & Infection
133:
291–298.
|
|
|
Hyypia T,
Horsnell C,
Maaronen M et al.
(1992)
A distinct picornavirus group identified by sequence analysis.
Proceedings of the National Academy of Sciences of the USA
89:
8847–8851.
|
|
|
Kee F,
McElroy G,
Stewart D et al.
(1994)
A community outbreak of echovirus infection associated with an outdoor swimming pool.
Journal of Public Health Medicine
16:
145–148.
|
|
|
Khetsuriani N,
LaMonte‐Folwkes A,
Oberste MS and
Pallansch M
(2006b)
Neonatal enterovirus infections reported to the National Surveillance System in the United States, 1983–2003.
Pediatric Infectious Diseases Journal
25:
889–893.
|
|
|
Khetsuriani N,
LaMonte‐Folwkes A,
Oberste MS et al.
(2006a)
Enterovirus Surveillance – United States, 1970–2005.
Morbidity and Mortality Weekly Report
55(SS‐8):
1–24.
|
|
|
ePath
Knowles N
(2011). Picornaviridae: Enterovirus. http://www.picornaviridae.com/enterovirus/enterovirus.htm
|
|
|
book
Knowles NJ,
Hove T,
King AMQ and
Stanway G
(2010)
"Overview of taxonomy".
In: Ehrenfeld E,
Domingo E and
Roos RP (eds)
The Picornaviruses,
pp. 19–32.
Washington, DC: American Society of Microbiology.
|
|
|
Melnick JL,
Shaw EW and
Curnen EC
(1949)
A virus isolated from patients diagnosed as non‐paralytic poliomyelitis or aseptic meningitis.
Proceeding of the Society of Experimental Biology and Medicine
71:
344–349.
|
|
|
Mirkovic RR,
Kono R,
Yin‐Murphy M et al.
(1973)
Enterovirus type 70: the etiologic agent of pandemic acute haemorrhagic conjuctivitis.
Bulletin of the World Health Organization
49:
341–346.
|
|
|
book
Morens DM and
Pallansch MA
(1995)
"Epidemiology".
In: Rotbart HA (ed.)
Human Enterovirus Infections,
pp. 3–23.
Washington, DC: American Society for Microbiology.
|
|
|
Oberste MS,
Maher K and
Pallansch MA
(1998)
Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses.
Virus Research
56:
217–223.
|
|
|
Oberste MS,
Maher K,
Kennett ML et al.
(1999a)
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.
Journal of Clinical Microbiology
37:
3928–3933.
|
|
|
Oberste MS,
Maher K,
Kennett ML et al.
(1999d)
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.
Journal of Clinical Microbiology
37:
3928–3933.
|
|
|
Oberste MS,
Maher K,
Kilpatrick DR and
Pallansch MA
(1999c)
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.
Journal of Virology
73:
1941–1948.
|
|
|
Oberste MS,
Maher K,
Kilpatrick DR et al.
(1999b)
Typing of human enteroviruses by partial sequencing of VP1.
Journal of Clinical Microbiology
37:
1288–1293.
|
|
|
Oberste MS,
Nix WA,
Kilpatrick DR et al.
(2003)
Molecular epidemiology and type‐specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East.
Virus Research
91:
241–248.
|
|
|
Papa A,
Skoura L,
Dumaidi K et al.
(2009)
Molecular epidemiology of Echovirus 6 in Greece.
European Journal of Clinical Microbiology and Infectious Diseases
28:
683–687.
|
|
|
Powell RM,
Ward T,
Goodfellow I,
Almond JW and
Evans DJ
(1999)
Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses; implications for the evolution of a DAF‐binding phenotype.
Journal of General Virology
80:
3145–3152.
|
|
|
book
Racaniello VR
(2007)
"Picornaviridae: the viruses and their replication".
In: Fields BN,
Knipe DM and
Howley PM et al. (eds)
Fields Virology,
5th edn,
pp. 795–838.
Philadelphia: Lippincott Williams & Wilkins.
|
|
|
Ramers C,
Billman G,
Hartin M et al.
(2000)
Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management.
Journal of the American Medical Association
283:
2680–2685.
|
|
|
Rico‐Hesse R,
Pallansch MA,
Nottay BK and
Kew OM
(1987)
Geographic distribution of wild poliovirus type 1 genotypes.
Virology
160:
311–322.
|
|
|
Rogers JM,
Diana GD and
McKinlay MA
(1999)
Pleconaril. A broad spectrum antipicornaviral agent.
Advances in Experimental Medicine and Biology
458:
69–76.
|
|
|
Romero JR
(1999)
Reverse‐transcription polymerase chain reaction detection of the enteroviruses.
Archives of Pathology and Laboratory Medicine
123:
1161–1169.
|
|
|
Romero JR
(2001)
Pleconaril: a novel antipicornaviral drug.
Expert Opinion in Investigational Drugs
10:
369–379.
|
|
|
book
Romero JR
(2009)
"Enteroviruses". In
Richman DD,
Whitley RJ and
Hayden FG (eds)
Clinical Virology,
3rd edn,
pp. 1031–1062.
Washington, DC: American Society for Microbiology Press.
|
|
|
Rotbart HA,
Webster AD and
Pleconaril Treatment Registry Group
(2001)
Treatment of potentially life‐threatening enterovirus infections with pleconaril.
Clinical Infectious Diseases
32:
228–235.
|
|
|
van der Sanden S,
Koopmans M,
Uslu G et al.
(2009)
Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.
Journal of Clinical Microbiology
47:
2826–2833.
|
|
|
Stanway G and
Hyypia T
(1999)
Parechoviruses.
Journal of Virology
73:
5249–5254.
|
|
|
book
Stellrecht KA,
Lamson DA and
Romero JR
(2011)
"Entroviruses and parechoviruses".
In: Murray PR,
Baron EJ,
Jorgensen JH,
Landry ML and
Pfaller MA (eds)
Manual of Clinical Microbiology,
10th edn,
pp. 1388–1399.
Washington, DC: American Society for Microbiology.
|
|
|
Yeung WC,
Rawlinson WD and
Craig ME
(2011)
Enterovirus infection and type 1 diabetes mellitus: systematic review and meta‐analysis of observational molecular studies.
British Medical Journal
342:
1–9.
|
| Further Reading |
|
|
book
Cherry JD and
Krogstad P
(2009)
"Enteroviruses and Parechoviruses".
In: Feigin RD,
Cherry JD,
Demmler‐Harrison GJ and
Kaplan SL (eds)
Textbook of Pediatric Infectious Diseases,
5th edn,
pp. 2110–2170.
Philadelphia: WB Saunders.
|
|
|
Coller BA,
Chapman NM,
Beck MA et al.
(1990)
Echovirus 22 is an atypical enterovirus.
Journal of Virology
64:
2692–2701.
|
|
|
book
Rotbart HA (ed.)
(1995)
Human Enterovirus Infections.
Washington, DC: ASM Press.
|
|
|
Rotbart HA,
Romero JR,
Modlin JF and
Sawyer MH
(1999)
Clinical and pharmacologic considerations for viral meningitis.
Infections in Medicine
16(suppl. D):
1–32.
|
